Latest Medical Research News and Research
Updated: 54 min 20 sec ago
A study in the Philadelphia area found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants evolve to become more contagious and resistant to COVID-19 vaccines. In addition, depending on the sublineage, SARS-CoV-2 variants such as the Delta variant led to a three-fold increased risk for vaccine breakthrough cases.
Antibiotics are now an accepted first-line treatment for most people with appendicitis, according to final results of the Comparing Outcomes of antibiotic Drugs and Appendectomy (CODA) trial, and an updated treatment guideline for appendicitis from the American College of Surgeons.
Researchers in the UK have conducted a study suggesting that the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – is transmitted more quickly than previously circulating variants.
Researchers have long known that air pollution can increase the risk of disorders such as obesity, diabetes, and fertility, but they did not know the exact mechanism for how it can lead to these health conditions.
Stimulant use linked with increased risk of cardiovascular events among older adults in the first month
New research led by Mina Tadrous, Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto shows that use of prescription stimulant medications in older adults increased the risk of a cardiovascular events by 40 per cent within the first thirty days of medication use.
Fewer, higher doses of post-prostatectomy radiation therapy does not increase long-term side effects
Using fewer-;but higher-;doses of radiation to treat men with prostate cancer who had their prostates removed does not increase long-term side effects or lower their quality of life compared to conventional radiation treatment, a new, multi-institutional clinical trial shows.
A team of researchers has demonstrated that the impact of the coronavirus disease 2019 (COVID-19) pandemic on excess mortality varied widely both between and within five European countries in 2020.
Lipopolysaccharide, a virulence factor produced by bacteria, is a toxin that can cause a systemic inflammation via the circulation. In a recently completed study, genetic markers were discovered which are associated with a heightened lipopolysaccharide level in the blood.
Keeping blood insulin levels within strict, healthy parameters is a daily goal for people with diabetes. But now, researchers from Japan have found that regulating blood insulin levels may even help lower the risk of getting COVID-19.
Use of financial incentives in two low-risk randomized clinical trials did not present ethical issues, and in one of the trials, the incentives increased study participation, according to findings published in JAMA Internal Medicine.
In a recent review, the author discusses autophagy as a contributing mechanism of selected drugs that are currently being evaluated to treat COVID‐19.
Researchers at Karolinska Institutet in Sweden have analyzed the presence of SARS-CoV-2-specific antibodies and memory cells of the immune system in young adults.
One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.
A new meta-analysis finds that a genetic biomarker test accurately predicts how men with high-risk prostate cancer will respond to treatment with radiation and hormone therapy.
The use of opioids, methamphetamines, cocaine and other stimulants is the second-most-common cause of exposure to HIV among those in the United States diagnosed with the virus that causes AIDS.
U of M Udall Center receives $11.3 million grant to continue research on deep brain stimulation for Parkinson’s disease
The Udall Center at the University of Minnesota Medical School was awarded a new $11.3 million grant from the National Institute for Neurological Disorders and Stroke to continue its work in deep brain stimulation (DBS) for Parkinson's disease.
News-Medical speaks to Professor Tomohiro Kurosaki about how he has developed a new vaccine approach that could prevent future pandemics.
Researchers from EMIT bio have developed a biological light unit that can sterilize surfaces, killing SARS-CoV-2.
Researchers have been investigating the potential for SARS-CoV-2 to spread to NHP through wastewater.
Researchers have been investigating the changes in receptor binding in these variants that increase the danger they pose.